human gallbladder epithelial cell line gbec (iCell Bioscience Inc)
Structured Review

Human Gallbladder Epithelial Cell Line Gbec, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human gallbladder epithelial cell line gbec/product/iCell Bioscience Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Effect of nicotine on cholesterol gallstone formation in C57BL/6J mice fed on a lithogenic diet"
Article Title: Effect of nicotine on cholesterol gallstone formation in C57BL/6J mice fed on a lithogenic diet
Journal: Experimental and Therapeutic Medicine
doi: 10.3892/etm.2023.11783
Figure Legend Snippet: Effect of nicotine on cholesterol metabolism by regulating in the gallbladder epithelial tissues. (A) mRNA levels of bile acid metabolism in the gallbladder epithelial tissues of mice injected with nicotine was measured by quantitative polymerase chain reaction (n=3). (B) Representative western blot analyses and (C-E) immunohistochemical staining of FXR and megalin (magnification, x100). Data are expressed as the mean ± standard deviation of the mean (n=10 mice per group). * P<0.05 vs. the ND group; # P<0.05 vs. the LD group. ND, normal diet; LD, lithogenic diet; H, 6.6 mg/kg/2 days nicotine; L, 1.1 mg/kg/2 days nicotine; NPC1L1, NPC1 like intracellular cholesterol transporter 1; ABC, ATP-binding cassette; SR-BI, scavenger receptor class B member 1; FXR, farnesoid X receptor.
Techniques Used: Injection, Real-time Polymerase Chain Reaction, Western Blot, Immunohistochemical staining, Staining, Standard Deviation, Binding Assay
Figure Legend Snippet: Effect of nicotine on the regulation of FXR/megalin/cubilin in the gallbladder epithelial cells. (A) GBEC cells were treated with 2 µM nicotine for 48 h, then total cell lysates (40 µg) from GBECs were subjected to western blot analysis. (B) Immunofluorescence for megalin in confluent GBECs treated with nicotine for 48 h in the presence of FXR agonist CDCA (10 µM; magnification, x100). * P<0.05 vs. control; # P<0.05 vs. the CDCA. FXR, farnesoid X receptor; CDCA, chenodeoxycholic acid.
Techniques Used: Western Blot, Immunofluorescence, Control